Detalhe da pesquisa
1.
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Breast Cancer Res Treat
; 204(2): 237-248, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112922
2.
Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy (IRENE) in Locally Advanced or Metastatic Breast Cancer: Prospective Cohort Study.
Oncologist
; 28(12): e1152-e1159, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37555463
3.
Chronic unilateral arm lymphedema correlates with increased intima-media thickness in the brachial artery.
Vasa
; 51(1): 19-23, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34872377
4.
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(5): 620-631, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743851
5.
[Predictors of the Utilization and Waiting Period Before Starting an Oncological Rehabilitation after Breast Cancer]. / Prädiktoren der Inanspruchnahme und des Beginns einer onkologischen Rehabilitation nach Brustkrebs.
Rehabilitation (Stuttg)
; 60(2): 86-94, 2021 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-33858017
6.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Lancet Oncol
; 21(5): 699-709, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32305099
7.
Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883).
J Med Genet
; 56(9): 574-580, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30979843
8.
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
Br J Cancer
; 118(8): 1123-1129, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29555990
9.
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer.
Invest New Drugs
; 36(5): 848-859, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29349598
10.
Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer.
Breast Cancer Res Treat
; 162(1): 31-37, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28062980
11.
Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.
Genet Med
; 19(5): 599-603, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27711073
12.
Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8).
Gynecol Oncol
; 140(3): 450-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26731724
13.
Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry.
Int J Mol Sci
; 17(10)2016 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27669228
14.
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Lancet Oncol
; 16(8): 928-36, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26115797
15.
Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer.
Breast Cancer Res Treat
; 149(1): 141-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25519041
16.
Recommendations Related to Genetic Testing for Breast Cancer.
JAMA
; 323(2): 188, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31935022
17.
CYP2B6*6 is associated with increased breast cancer risk.
Int J Cancer
; 134(2): 426-30, 2014 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23824676
18.
The role of genetic breast cancer susceptibility variants as prognostic factors.
Hum Mol Genet
; 21(17): 3926-39, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22532573
19.
Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line.
BMC Cancer
; 14: 434, 2014 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24928521
20.
The Safety and Efficacy of the Combination of Sacituzumab Govitecan and Palliative Radiotherapy-A Retrospective Multi-Center Cohort Study.
Cancers (Basel)
; 16(9)2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38730602